| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.35 | 4e-20 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.36 | 2e-18 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.31 | 8e-16 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.3 | 6e-13 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.43 | 4e-10 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.32 | 2e-09 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.36 | 3e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 5e-09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-09 |